vimarsana.com

Page 5 - Pascal Touchon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Atara Biotherapeutics to Present Recent Progress and Key Upcoming Milestones at the 42nd Annual J P Morgan Healthcare Conference

Closing of Transaction with Pierre Fabre Laboratories to Expand Global Tab-cel® Partnership Tab-cel BLA on Track for Submission in Q2 2024 Following Positive New Data from Pivotal ALLELE.

United statesPierre fabrePascal touchonAtara biotherapeutics incSecurities exchangeExchange commissionOncology annual congressChief executive officerHealthcare conferenceLupus nephritisPost transplant lymphoproliferative diseaseBiologics license applicationObjective response ratePotential indicationHematological malignanciesAutoimmune conditions

Atara Biotherapeutics to Present at the 42nd Annual J P Morgan Healthcare Conference

Atara Biotherapeutics to Present at the 42nd Annual J P Morgan Healthcare Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesPascal touchonAtara biotherapeutics incChief executive officerHealthcare conference

Atara Biotherapeutics to Present at the 42nd Annual J P Morgan Healthcare Conference

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus T-cell platform to develop transformative therapies for patients with cancer and.

San franciscoUnited statesPascal touchonAtara biotherapeutics incChief executive officerHealthcare conference

Atara Biotherapeutics, Inc (NASDAQ:ATRA) Receives Average Recommendation of Hold from Analysts

Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have earned an average recommendation of “Hold” from the three analysts that are presently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation. The average 1 year price target among brokers that have updated their coverage on the […]

United statesPascal touchonAnhco nguyenAtara biotherapeutics incPricet rowe associates incStaley capital advisers incCapital managementSecurities exchange commissionRedmile groupAcadian asset managementGet free reportMarketbeat ratingsExchange commissionAsset managementStaley capital advisersCapital advisers

Atara Biotherapeutics to Participate at the 6th Annual Evercore ISI HealthCONx Conference

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus T-cell platform to develop transformative therapies for patients with cancer and.

United statesPascal touchonAtara biotherapeutics incChief executive officerAnnual evercore

vimarsana © 2020. All Rights Reserved.